Regulus Therapeutics Inc (RGLS) — Cash Flow Reinvestment Rate
Regulus Therapeutics Inc (RGLS) has a Cash Flow Reinvestment Rate of 0.07x as of December 2020, reinvesting $237.00K (capex $237.00K ) from operating cash flow of $3.19 Million. Explore how much does Regulus Therapeutics Inc reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Regulus Therapeutics Inc Cash Flow Reinvestment Rate (2010–2010)
Historical reinvestment intensity for Regulus Therapeutics Inc across 1 annual periods. Also explore RGLS asset base for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Regulus Therapeutics Inc (2010–2010)
Year-by-year capital reinvestment analysis for Regulus Therapeutics Inc. For live market cap and broader valuation context, see market value of Regulus Therapeutics Inc.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2010 | 0.20x | $2.42 Million | $12.31 Million | $2.42 Million | — |